Literature DB >> 24327759

Phase portraits of the proliferation-quiescence decision.

Tongli Zhang1.   

Abstract

Mammalian cells make the proliferation or quiescence decision at a specific point in the cell cycle called the restriction point, after which they become committed to proliferation and independent of growth factors for completion of mitosis. In the textbook view, this crucial transition occurs several hours after mitotic division (in the middle of G1 phase). In a Cell paper, Spencer et al. show that the restriction point should be defined not as a particular time point in G1 phase but in terms of the ON-OFF status of a bistable switch that emerges from the positive feedback in the CDK2-RB-E2F (cyclin-dependent kinase 2-retinoblastoma-E2F) interaction network.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24327759     DOI: 10.1126/scisignal.2004891

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  4 in total

Review 1.  Cell cycle proliferation decisions: the impact of single cell analyses.

Authors:  Jacob P Matson; Jeanette G Cook
Journal:  FEBS J       Date:  2016-10-05       Impact factor: 5.542

2.  The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition.

Authors:  Claude Gérard; Albert Goldbeter
Journal:  Interface Focus       Date:  2014-06-06       Impact factor: 3.906

3.  Mathematical modelling reveals unexpected inheritance and variability patterns of cell cycle parameters in mammalian cells.

Authors:  Marzena Mura; Céline Feillet; Roberto Bertolusso; Franck Delaunay; Marek Kimmel
Journal:  PLoS Comput Biol       Date:  2019-06-03       Impact factor: 4.475

4.  Multiscale positive feedbacks contribute to unidirectional gastric disease progression induced by helicobacter pylori infection.

Authors:  Richard Ballweg; Frederick Schozer; Kelsey Elliott; Alexander Kuhn; Logan Spotts; Eitaro Aihara; Tongli Zhang
Journal:  BMC Syst Biol       Date:  2017-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.